Voriconazole Inhibition of the Metabolism of Tacrolimus in a Liver Transplant Recipient and in Human Liver Microsomes
AUTOR(ES)
Venkataramanan, Raman
FONTE
American Society for Microbiology
RESUMO
The purpose of this study was to assess the effect of voriconazole on the blood tacrolimus concentration in a liver transplant recipient and to examine the interaction between voriconazole and tacrolimus by using human liver microsomes. Two subjects were enrolled in the clinical study: one received voriconazole, and the other received a placebo. Tacrolimus metabolism was evaluated in human liver microsomes at various concentrations in the absence and presence of various concentrations of voriconazole. Coadministration of voriconazole and tacrolimus resulted in elevated (nearly 10-fold-higher) trough tacrolimus blood concentrations in the liver transplant patient. In the in vitro study, voriconazole at a concentration of 10.4 ± 4.3 μg/ml inhibited the metabolism of tacrolimus by 50%. Clinically relevant concentrations of voriconazole inhibited the metabolism of tacrolimus in human liver microsomes. Close monitoring of the blood concentration and adjustment in the dose of tacrolimus are warranted in transplant recipients treated with voriconazole.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=127452Documentos Relacionados
- Paracoccidioidomycosis in a liver transplant recipient
- In vitro metabolism of copalic and kaurenoic acids in rat and human liver microsomes
- In vitro effect of fluoroquinolones on theophylline metabolism in human liver microsomes.
- Chronic Cholangitis Caused by Bordetella hinzii in a Liver Transplant Recipient
- Cranberry juice suppressed the diclofenac metabolism by human liver microsomes, but not in healthy human subjects
